In both groups, copeptin levels were higher in participants with metabolic syndrome with positive correlation with insulin levels and HOMA-IR and independent association with adiposity and dyslipidemia, suggesting that copeptin may be a novel marker of insulin resistance and metabolic syndrome. The gene discussed is INS; the disease is Insulin resistance.